| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | Ausblick | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 94.96 |
| Victory Sycamore Established Value Fund | 1.48 |
| Pictet Asset Management Ltd. | 1.07 |
| Avidity Partners Management LP | 0.65 |
| Ceredex Value Advisors LLC | 0.53 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 45’000 | 46’000 | 47’000 | 49’000 | 49’000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.17 | 0.16 | 0.16 | 0.19 | 0.22 |
Bilanz (in Mio. EUR) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1’306 | 1’390 | 2’490 | 3’058 | 2’741 |
| Summe Anlagevermögen | 8’776 | 9’207 | 11’057 | 11’567 | 11’217 |
| Summe Aktiva | 10’503 | 11’003 | 12’843 | 14’026 | 13’611 |
Bilanz (in Mio. EUR) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 3’855 | 3’991 | 5’416 | 4’808 | 4’773 |
| Summe Fremdkapital | 5’468 | 5’659 | 7’080 | 7’135 | 7’049 |
| Summe Eigenkapital | 5’035 | 5’344 | 5’763 | 6’891 | 6’562 |
| Summe Passiva | 10’503 | 11’003 | 12’843 | 14’026 | 13’611 |
Adresse
| 500 Plaza Drive, 07940 Secaucus | |
| Telefon | +1 (973) 520-2700 |
| URL | http://www.questdiagnostics.com |
Management
|
Alyssa Waxenberg
Director-Digital Products & Consumer Marketing |
|
Carrie Eglinton Manner
Senior Vice President-Advanced Diagnostics |
|
Catherine T. Doherty
Senior Vice President & Group Executive-Marketing |
|
Cecilia K. McKenney
Chief Human Resources Officer & Senior VP |
|
Denise M. Morrison
Independent Director |
|
Dermot Victor Shorten
Senior Vice President-Ventures, Strategy, M&A |
|
Doug Lang
Director-Technical Products |
|
Gabrielle Wolfson
SVP, Chief Information & Digital Officer |
|
Gail R. Wilensky
Independent Director |
|
Gary M. Pfeiffer
Independent Director |
|
Helen I. Torley
Independent Director |
|
James E. Davis
Chief Executive Officer-Elect |
|
Jay G. Wohlgemuth
Chief Medical Officer, Senior VP-R&D, Medical |
|
Mark E. Delaney
Chief Commercial Officer & Senior Vice President |
|
Mark J. Guinan
Chief Financial Officer & Executive Vice President |
|
Michael E. Prevoznik
General Counsel, Senior VP-Legal & Compliance |
|
Michael Joseph Deppe
Chief Accounting Officer, VP & Controller |
|
Shawn Bevec
Vice President-Investor Relations |
|
Stephen H. Rusckowski
Chairman, President & Chief Executive Officer |
|
Timothy L. Main
Independent Director |
|
Timothy M. Ring
Lead Independent Director |
|
Timothy U. Sharpe
Vice President-Compliance |
|
Tracey C. Doi
Independent Director |
|
Tracy L. Cinco-Abela
Treasurer & Vice President |
|
Vicky B. Gregg
Independent Director |
|
William J. O'Shaughnessy
Secretary & Deputy General Counsel |
|
Wright L. Lassiter
Independent Director |